HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses

被引:75
作者
Col, E
Caron, C
Chable-Bessia, C
Legube, G
Gazzeri, S
Komatsu, Y
Yoshida, M
Benkirane, M
Trouche, D
Khochbin, S
机构
[1] Fac Med, Inst Albert Bonniot, Equipe Chromatine & Express Genes, INSERM,U309,Lab Biol Mol & Cellulaire Differencia, F-38706 La Tronche, France
[2] Inst Genet Humaine, Mol Virol Lab, CNRS, UPR1142, Montpellier, France
[3] Univ Toulouse 3, Lab Biol Mol Eucaryote, CNRS, UMR 5099, F-31062 Toulouse, France
[4] Fac Med, Inst Albert Bonniot, INSERM, U578,Grp Rech Canc Poumon, La Tronche, France
[5] CREST Res Project, Kawaguchi, Saitama, Japan
[6] RIKEN, Chem Genet Lab, Saitama, Japan
关键词
chromatin; HAT; HDAC; ubiquitin; E4;
D O I
10.1038/sj.emboj.7600734
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HIV-1 transactivator Tat uses cellular acetylation signalling by targeting several cellular histone acetyltransferases (HAT) to optimize its various functions. Although Tip60 was the first HAT identified to interact with Tat, the biological significance of this interaction has remained obscure. We had previously shown that Tat represses Tip60 HAT activity. Here, a new mechanism of Tip60 neutralization by Tat is described, where Tip60 is identified as a substrate for the newly reported p300/CBP-associated E4-type ubiquitin-ligase activity, and Tat uses this mechanism to induce the polyubiquitination and degradation of Tip60. Tip60 targeting by Tat results in a dramatic impairment of the Tip60-dependent apoptotic cell response to DNA damage. These data reveal yet unknown strategies developed by HIV-1 to increase cell resistance to genotoxic stresses and show a role of Tat as a modulator of cellular protein ubiquitination.
引用
收藏
页码:2634 / 2645
页数:12
相关论文
共 53 条
[1]   Apoptosis in HIV-1 infection [J].
Bell, DJ ;
Dockrell, DH .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2003, 17 (02) :178-183
[2]   HIV-Tat promotes cellular proliferation and inhibits NGF-induced differentiation through mechanisms involving Id1 regulation [J].
Bergonzini, V ;
Delbue, S ;
Wang, JY ;
Reiss, K ;
Prisco, M ;
Amini, S ;
Khalili, K ;
Peruzzi, F .
ONCOGENE, 2004, 23 (46) :7701-7711
[3]   A large-scale RNAi screen in human cells identifies new components of the p53 pathway [J].
Berns, K ;
Hijmans, EM ;
Mullenders, J ;
Brummelkamp, TR ;
Velds, A ;
Heimerikx, M ;
Kerkhoven, RM ;
Madiredjo, M ;
Nijkamp, W ;
Weigelt, B ;
Agami, R ;
Ge, W ;
Cavet, G ;
Linsley, PS ;
Beijersbergen, RL ;
Bernards, R .
NATURE, 2004, 428 (6981) :431-437
[4]   A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter [J].
Brès, V ;
Kiernan, RE ;
Linares, LK ;
Chable-Bessia, C ;
Plechakova, O ;
Tréand, C ;
Emiliani, S ;
Peloponese, JM ;
Jeang, KT ;
Coux, O ;
Scheffner, M ;
Benkirane, M .
NATURE CELL BIOLOGY, 2003, 5 (08) :754-761
[5]   Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation [J].
Brooks, CL ;
Gu, W .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :164-171
[6]   HIV type 1 Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells [J].
Cantaluppi, V ;
Biancone, L ;
Boccellino, M ;
Doublier, S ;
Benelli, R ;
Carlone, S ;
Albini, A ;
Camussi, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (10) :965-976
[7]   The viral control of cellular acetylation signaling [J].
Caron, C ;
Col, E ;
Khochbin, S .
BIOESSAYS, 2003, 25 (01) :58-65
[8]   Regulatory cross-talk between lysine acetylation and ubiquitination: role in the control of protein stability [J].
Caron, C ;
Boyault, C ;
Khochbin, S .
BIOESSAYS, 2005, 27 (04) :408-415
[9]   Intracellular human immunodeficiency virus tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport [J].
Chauhan, A ;
Turchan, J ;
Pocernich, C ;
Bruce-Keller, A ;
Roth, S ;
Butterfield, DA ;
Major, EO ;
Nath, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) :13512-13519
[10]   HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression [J].
Chipitsyna, G ;
Slonina, D ;
Siddiqui, K ;
Peruzzi, F ;
Skorski, T ;
Reiss, K ;
Sawaya, BE ;
Khalili, K ;
Amini, S .
ONCOGENE, 2004, 23 (15) :2664-2671